Prognostic value of stress echocardiography assessed by the ABCDE protocol

Ciampi, Quirino; Zagatina, Angela; Cortigiani, Lauro; Wierzbowska-Drabik, Karina; Kasprzak, Jaroslaw D; Haberka, Maciej; Djordjevic-Dikic, Ana; Beleslin, Branko; Boshchenko, Alla; Ryabova, Tamara; Gaibazzi, Nicola; Rigo, Fausto; Dodi, Claudio; Simova, Iana; Samardjieva, Martina; Barbieri, Andrea; Morrone, Doralisa; Lorenzoni, Valentina; Prota, Costantina; Villari, Bruno; Antonini-Canterin, Francesco; Pepi, Mauro; Carpeggiani, Clara; Pellikka, Patricia A; Picano, Eugenio

AIM: The aim of this study was to assess the prognostic value of ABCDE-SE in a prospective, large scale, multicentre, international, effectiveness study. Stress echocardiography (SE) was recently upgraded to the ABCDE protocol: step A, regional wall motion abnormalities; step B, B lines; step C, left ventricular contractile reserve; step D, Doppler-based coronary flow velocity reserve in left anterior descending coronary artery; and step E, electrocardiogram-based heart rate reserve. METHODS AND RESULTS: From July 2016 to November 2020, we enrolled 3574 all-comers (age 65 ± 11 years, 2070 males, 58%; ejection fraction 60 ± 10%) with known or suspected chronic coronary syndromes referred from 13 certified laboratories. All patients underwent clinically indicated ABCDE-SE. The employed stress modality was exercise (n = 952, with semi-supine bike, n = 887, or treadmill, n = 65 with adenosine for step D) or pharmacological stress (n = 2622, with vasodilator, n = 2151; or dobutamine, n = 471). SE response ranged from score 0 (all steps normal) to score 5 (all steps abnormal). All-cause death was the only endpoint. Rate of abnormal results was 16% for A, 30% for B, 36% for C, 28% for D, and 37% for E steps. During a median follow-up of 21 months (interquartile range: 13–36), 73 deaths occurred. Global X(2) was 49.5 considering clinical variables, 50.7 after step A only (P = NS (not significant)) and 80.6 after B–E steps (P < 0.001 vs. step A). Annual mortality rate ranged from 0.4% person-year for score 0 up to 2.7% person-year for score 5. CONCLUSION: ABCDE-SE allows an effective prediction of survival in patients with chronic coronary syndromes.